E. Murat Tuzcu
Menzies Research Institute
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by E. Murat Tuzcu.
Circulation | 2013
Alper Ozkan; Rory Hachamovitch; Samir Kapadia; E. Murat Tuzcu; Thomas H. Marwick
Background— The optimal management of low-gradient “severe” aortic stenosis (mean gradient <40 mm Hg, indexed aortic valve area ⩽0.6 cm2/m2) with preserved left ventricular ejection fraction remains controversial because gradients may be similar after aortic valve replacement (AVR). We compared outcomes of low-gradient severe aortic stenosis with AVR or medical therapy. Methods and Results— Comprehensive echocardiographic measurements including hemodynamic calculations were completed in 260 prospectively identified patients with symptomatic low-gradient severe aortic stenosis. Patients were followed up for mortality over 28±24 months. AVR was performed in 123 patients (47%). Compared with AVR patients, medically treated patients had a higher prevalence of diabetes mellitus (25% versus 41%, P=0.009), lower stroke volume index (36.4±8.4 versus 34.4±8.7 mL/m2, P=0.02), higher pulmonary artery pressure (38±11 versus 48±21 mm Hg, P=0.001), and higher creatinine level (1.1±0.4 versus 1.22±0.5 mg/dL, P=0.02). These and other clinically relevant variables were entered into a propensity model that reflected likelihood of referral to AVR. This score and other variables were entered into a Cox model to explore the independent effect of AVR on outcome. During follow-up, 105 patients died (40%): 32 (30%) in the AVR group and 73 (70%) in the medical treatment group. AVR (hazard ratio, 0.54; 95% confidence interval, 0.32–0.94; P<0.001) was independently associated with outcome and remained a strong predictor of survival after adjustment for propensity score. Medical therapy was associated with 2-fold greater all-cause mortality than AVR. The protective effect of AVR was similar in 125 patients with normal flow (stroke volume index >35 mL/m2; P=0.22). Conclusions— AVR is associated with better survival than medical therapy in patients with symptomatic low-gradient severe AS and preserved left ventricular ejection fraction.
Archive | 2011
Bruce W. Lytle; Samir R. Kapadia; Shikhar Agarwal; E. Murat Tuzcu; Milind Y. Desai; Nicholas G. Smedira
Archive | 2011
Steven E. Nissen; Samir R. Kapadia; Stanley L. Hazen; Chuan-Chuan Wun; Michele Norton; Stephen J. Nicholls; E. Murat Tuzcu; Tim Crowe; Ilke Sipahi; Paul Schoenhagen
Archive | 2011
Russell E. Raymond; Eric J. Topol; Steven P. Marso; Stephen G. Ellis; E. Murat Tuzcu; Patrick L. Whitlow; Irving Franco
Archive | 2010
Craig Balog; Tim Crowe; Steven E. Nissen; Ilke Sipahi; E. Murat Tuzcu; Paul Schoenhagen; Katherine E. Wolski
Archive | 2009
Shikhar Agarwal; E. Murat Tuzcu; E. Rene Rodriguez; Carmela D. Tan; L. Leonordo Rodriguez; Samir R. Kapadia
Archive | 2008
Amy L. Seidel; Samir R. Kapadia; Harry M. Lever; E. Murat Tuzcu
Essential Interventional Cardiology (Second Edition) | 2008
Amy L. Seidel; Samir R. Kapadia; Harry M. Lever; E. Murat Tuzcu
Archive | 2004
Steven E. Nissen; E. Murat Tuzcu; Paul Schoenhagen; B. Greg Brown; Peter Ganz; Robert A. Vogel; Tim Crowe; Christopher J. Cooper; Bruce Brodie; Cindy L. Grines; Anthony N. DeMaria
Archive | 2004
Steven E. Nissen; E. Murat Tuzcu; Peter Libby; Paul D. Thompson; Magdi Ghali; Dahlia Garza; Lance Berman; Harry H. Shi; Eric J. Topol